Bladder Cancer Drug That Received Accelerated Approval Shows Even Stronger Findings in Later Study
According to a publication from Medscape, the first ever drug targeted for bladder cancer has shown even more impressive results in post-approval study. Erdafitinib was approved on an accelerated basis…